Yep,
The Directors reserve the right to place the shortfall of
1,744,513,321 ordinary shares under the Entitlement Offer within 3 months of the closing date of the Entitlement Offer at the same issue price of $0.003 per share.
However, I'm not convinced there have to be a sophisticated investor. Overall it is the shortfall under the Entitlement Offer and not a share placement.
vs
- Forums
- ASX - By Stock
- MST
- analysis of top 20 changes & conclusions
analysis of top 20 changes & conclusions, page-107
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MST (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online